The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study

被引:51
作者
Feingold, Daniel [1 ,2 ]
Brill, Silviu [3 ]
Goor-Aryeh, Itay [4 ]
Delayahu, Yael [5 ,6 ]
Lev-Ran, Shaul [2 ,6 ]
机构
[1] Ariel Univ, Ariel, Israel
[2] Lev Hasharon Med Ctr, Dual Diag Clin, Pardesiya, Israel
[3] Sourasky Med Ctr, Pain Ctr, Tel Aviv, Israel
[4] Sheba Med Ctr, Pain Ctr, Tel Hashomer, Israel
[5] Abarbanel Mental Hlth Ctr, Dept Dual Diag, Tel Aviv, Israel
[6] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
Chronic pain; Prescription opioids; Depression severity; Opioid misuse; QUALITY-OF-LIFE; NEGATIVE AFFECT; UNITED-STATES; RISK-FACTORS; HEALTH; PREVALENCE; ABUSE; DISORDERS; THERAPY; IMPACT;
D O I
10.1016/j.jad.2018.04.058
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In light of the increased rates of Prescription Opioid (PO) misuse and associated mortality in several developed countries in recent years, efforts have been made to identify populations who may be at increased risk for misuse of POs. Though the association between depression and PO misuse among pain patients is well documented, little is known regarding the effects of severity of depression on rates of misuse. In this study we explored rates of PO misuse among chronic pain patients screening positive for depression according to level of severity. Methods: Participants included chronic pain patients receiving POs (N = 554). All participants were screened for depression using the Patient Health Questionnaire (PHQ-9; cut-off scores of 5, 10, 15, and 20 for mild, moderate, moderate-severe and severe depression, respectively) and for opioid misuse using the Current Opioid Misuse Measure (COMM). Logistic regression analyses controlling for additional sociodemographic and clinical factors were conducted. Results: Participants who screened positive for depression were at significantly increased odds to screen positive for opioid misuse (Adjusted Odds Ratio (AOR) = 3.63; 95% Confidence Interval (CI) = 1.71-7.7) compared to those without depression. Severity of depression was significantly associated with increased odds for opioid misuse for moderate (AOR = 3.71; 95% CI = 1.01-13.76), moderate-severe (AOR = 6.28; 95% CI = 1.6-24.57) and severe (AOR = 14.66; 95% CI = 3.28-65.52) depression but not among those who screened positive for mild depression (AOR = 1.49; 95% CI = 0.39-5.68). Limitations: Cross-sectional study. Conclusions: Our results highlight the need to properly asses and address level of severity of co-morbid depression among chronic pain patients receiving POs.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 87 条
  • [21] The epidemiology of chronic pain in the community
    Elliott, AM
    Smith, BH
    Penny, KI
    Smith, WC
    Chambers, WA
    [J]. LANCET, 1999, 354 (9186) : 1248 - 1252
  • [22] Chronic pain, depression, and quality of life: Correlations and predictive value of the SF-36
    Elliott, TE
    Renier, CM
    Palcher, JA
    [J]. PAIN MEDICINE, 2003, 4 (04) : 331 - 339
  • [23] Misuse of prescription opioids among chronic pain patients suffering from anxiety: A cross-sectional analysis
    Feingold, Daniel
    Brill, Silviu
    Goor-Aryeh, Itay
    Delayahu, Yael
    Lev-Ran, Shaul
    [J]. GENERAL HOSPITAL PSYCHIATRY, 2017, 47 : 36 - 42
  • [24] Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain
    Feingold, Daniel
    Goor-Aryeh, Itay
    Bril, Silviu
    Delayahu, Yael
    Lev-Ran, Shaul
    [J]. PAIN MEDICINE, 2017, 18 (02) : 294 - 306
  • [25] The association between cannabis use and mood disorders: A longitudinal study
    Feingold, Daniel
    Weiser, Mark
    Rehm, Juergen
    Lev-Ran, Shaul
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2015, 172 : 211 - 218
  • [26] Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
    Fillingim, Roger B.
    King, Christopher D.
    Ribeiro-Dasilva, Margarete C.
    Rahim-Williams, Bridgett
    Riley, Joseph L., III
    [J]. JOURNAL OF PAIN, 2009, 10 (05) : 447 - 485
  • [27] COMORBIDITY AND DISEASE BURDEN IN THE NATIONAL COMORBIDITY SURVEY REPLICATION (NCS-R)
    Gadermann, Anne M.
    Alonso, Jordi
    Vilagut, Gemma
    Zaslavsky, Alan M.
    Kessler, Ronald C.
    [J]. DEPRESSION AND ANXIETY, 2012, 29 (09) : 797 - 806
  • [28] Garland Eric L, 2014, J Pain Palliat Care Pharmacother, V28, P122, DOI 10.3109/15360288.2014.911791
  • [29] The downward spiral of chronic pain, prescription opioid misuse, and addiction: Cognitive, affective, and neuropsychopharmacologic pathways
    Garland, Eric L.
    Froeliger, Brett
    Zeidan, Fadel
    Partin, Kaitlyn
    Howard, Matthew O.
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2013, 37 (10) : 2597 - 2607
  • [30] The Economic Costs of Pain in the United States
    Gaskin, Darrell J.
    Richard, Patrick
    [J]. JOURNAL OF PAIN, 2012, 13 (08) : 715 - 724